Assessment of 14 functional gene polymorphisms in Japanese patients with oral lichen planus: a pilot case-control study

International Journal of Oral and Maxillofacial Surgery

Volumn 38, Issue 9, 2009, Pages 978-983

  Fujita, H ^a   Kobayashi, T ^b   Tai, H ^a   Nagata, M ^a   Hoshina, H ^a   Nishizawa, R ^a   Takagi, R ^a   Yoshie, H ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

gene polymorphisms; Japanese patients; oral lichen planus; tumor necrosis factor receptor 2

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DNA ISOLATION; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENE AMPLIFICATION; GENE CONTROL; GENE FREQUENCY; GENETIC RISK; GENETIC SCREENING; GENOTYPE; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; INFORMED CONSENT; LICHEN PLANUS; MALE; MOUTH CAVITY; NORMAL HUMAN; PATHOGENESIS; PATIENT SELECTION; PILOT STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PILOT PROJECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, POLYMERIC IMMUNOGLOBULIN; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REFERENCE VALUES; RISK FACTORS;

EID: 69749114289     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2009.05.001     Document Type: Article

References (42)

1. Baker E., Chen L.Z., Smith C.A., Callen D.F., Goodwin R., and Sutherland G.R. Chromosomal location of the human tumor necrosis factor receptor genes. Cytogenet Cell Genet 57 (1991) 117-118
2. Barton A., John S., Ollier W.E., Silman A., and Worthington J. Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor II, but not tumor necrosis factor receptor I, in Caucasians. Arthritis Rheum 44 (2001) 61-65
3. Bloor B.K., Seddon S.V., and Morgan P.R. Gene expression of differentiation- specific keratins (K4, K13, K1 and K10) in oral non-dysplastic keratoses and lichen planus. J Oral Pathol Med 29 (2000) 376-384
4. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., and Mattson M.P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 2 (1996) 788-794
5. Carrozzo M., Dametto E., Fasano M.E., Arduino P., Bertolusso G., Uboldi de Capei F., Rendine S., and Amoroso A. Cytokine gene polymorphisms in hepatitis C virus-related oral lichen planus. Exp Dermatol 16 (2007) 730-736
6. Carrozzo M., Gandolfo S., Lodi G., Carbone M., Garzino-Demo P., Carbonero C., Porter S.R., and Scully C. Oral lichen planus in patients infected or noninfected with hepatitis C virus: the role of autoimmunity. J Oral Pathol Med 28 (1999) 16-19
7. Carrozzo M., Uboldi de Capei M., Dametto E., Fasano M.E., Arduino P., Broccoletti R., Vezza D., Rendine S., Curtoni E.S., and Gandolfo S. Tumor necrosis factor-α and interferon-γ polymorphisms contribute to susceptibility to oral lichen planus. J Invest Dermatol 122 (2004) 87-94
8. Fabris M., Tolusso B., Di Poi E., Assaloni R., Sinigaglia L., and Ferraccioli G. Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis. J Rheumatol 29 (2002) 1847-1850
9. Gu G.M., Martin M.D., Darveau R.P., Truelove E., and Epstein J. Oral and serum IL-6 levels in oral lichen planus patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98 (2004) 673-678
10. Hall J.G., Eis P.S., Law S.M., Reynaldo L.P., Prudent J.R., Marshall D.J., Allawi H.T., Mast A.L., Dahlberg J.E., Kwiatkowski R.W., de Arruda M., Neri B.P., and Lyamichev V.I. Sensitive detection of DNA polymorphisms by the serial invasive signal amplification reaction. Proc Natl Acad Sci USA 97 (2000) 8272-8277
11. Hohjoh H., Terada N., Kawashima M., Honda Y., and Tokunaga K. Significant association of the tumor necrosis factor receptor 2 (TNFR2) gene with human narcolepsy. Tissue Antigens 56 (2000) 446-448
12. Hsu T.M., Law S.M., Duan S., Neri B.P., and Kwok P.Y. Genotyping single-nucleotide polymorphisms by the invader assay with dual-color fluorescence polarization detection. Clin Chem 47 (2001) 1373-1377
13. Ishikawa Y., Kashiwase K., Akaza T., Morishima Y., Inoko H., Sasazuki T., Kodera Y., and Juji T. Polymorphisms in TNFA and TNFR2 affect outcome of unrelated bone marrow transplantation. Bone Marrow Transplant 29 (2002) 569-575
14. Kaufman B.A., White P.S., and Brodeur G. A complex single strand conformational polymorphism (SSCP) in the tumor necrosis factor receptor 2 (TNFR2) gene on chromosome 1p36.2. Hum Mol Genet 2 (1993) 824
15. Kobayashi T., Westerdaal N.A., Miyazaki A., van der Pol W.L., Suzuki T., Yoshie H., van de Winkel J.G., and Hara K. Relevance of immunoglobulin G Fc receptor polymorphism to recurrence of adult periodontitis in Japanese patients. Infect Immun 65 (1997) 3556-3560
16. Kobayashi T., Sugita N., van der Pol W.L., Nunokawa Y., Westerdaal N.A., Yamamoto K., van de Winkel J.G., and Yoshie H. The Fcγ receptor genotype as a risk factor for generalized early-onset periodontitis in Japanese patients. J Periodontol 71 (2000) 1425-1432
17. Kobayashi T., Ito S., Yasuda K., Kuroda T., Yamamoto K., Sugita N., Tai H., Narita I., Gejyo F., and Yoshie H. The combined genotypes of stimulatory and inhibitory Fcγ receptors associated with systemic lupus erythematosus and periodontitis in Japanese adults. J Periodontol 78 (2007) 467-474
18. Koch P., and Bahmer F.A. Oral lesions and symptoms related to metals used in dental restorations: a clinical, allergological, and histologic study. J Am Acad Dermatol 41 (1999) 422-430
19. Komata T., Tsuchiya N., Matsushita M., Hagiwara K., and Tokunaga K. Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus. Tissue Antigens 53 (1999) 527-533
20. Kyogoku C., Dijstelbloem H.M., Tsuchiya N., Hatta Y., Kato H., Yamaguchi A., Fukazawa T., Jansen M.D., Hashimoto H., van de Winkel J.G., Kallenberg C.G., and Tokunaga K. Fcγ receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum 46 (2002) 1242-1254
21. Marino M.W., Dunn A., Grail D., Inglese M., Noguchi Y., Richards E., Jungbluth A., Wada H., Moore M., Williamson B., Basu S., and Old L.J. Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci USA 94 (1997) 8093-8098
22. Morita C., Horiuchi T., Tsukamoto H., Hatta N., Kikuchi Y., Arinobu Y., Otsuka T., Sawabe T., Harashima S., Nagasawa K., and Niho Y. Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis. Arthritis Rheum 44 (2001) 2819-2827
23. Nomura S., Kondo M., Nagano M., Matsui K., and Egashira T. Development of a novel nano-Invader DNA chip system. J Biochem Biophys Methods 70 (2007) 787-795
24. Pezelj-Ribaric S., Prso I.B., Abram M., Glazar I., Brumini G., and Simunovic-Soskic M. Salivary levels of tumor necrosis factor-alpha in oral lichen planus. Mediators Inflamm 13 (2004) 131-133
25. Pindborg J.J., Reichart P.A., Smith C.J., and van der Waal I. Histlogical typing of cancer and precancer of the oral mucosa. 2nd edn (1997), Springer-Verlag, Berlin, Heidelberg
26. Rhodus N.L., Cheng B., Myers S., Bowles W., Ho V., and Ondrey F. A comparison of the pro-inflammatory, NF-κB-dependent cytokines: TNF-α, IL-1-α, IL-6, and IL-8 in different oral fluids from oral lichen planus patients. Clin Immunol 114 (2005) 278-283
27. Rhodus N.L., Cheng B., Bowles W., Myers S., Miller L., and Ondrey F. Proinflammatory cytokine levels in saliva before and after treatment of (erosive) oral lichen planus with dexamethasone. Oral Dis 12 (2006) 112-116
28. Rothe J., Lesslauer W., Lotscher H., Lang Y., Koebel P., Kontgen F., Althage A., Zinkernagel R., Steinmetz M., and Bluethmann H. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364 (1993) 798-802
29. Shimada Y., Tai H., Endo M., Kobayashi T., Akazawa K., and Yamazaki K. Association of tumor necrosis factor receptor type 2 +587 gene polymorphism with severe chronic periodontitis. J Clin Periodontol 31 (2004) 463-469
30. Simark-Mattsson C., Bergenholtz G., Jontell M., Eklund C., Seymour G.J., Sugerman P.B., Savage N.W., and Dahlgren U.I. Distribution of interleukin-2, -4, -10, tumour necrosis factor-α and transforming growth factor-β mRNAs in oral lichen planus. Arch Oral Biol 44 (1999) 499-507
31. Sistig S., Vucicevic-Boras V., Lukac J., and Kusic Z. Salivary IgA and IgG subclasses in oral mucosal diseases. Oral Dis 8 (2002) 282-286
32. Sklavounou A., Chrysomali E., Scorilas A., and Karameris A. TNF-α expression and apoptosis-regulating proteins in oral lichen planus: a comparative immunohistochemical evaluation. J Oral Pathol Med 29 (2000) 370-375
33. Sklavounou-Andrikopoulou A., Chrysomali E., Iakovou M., Garinis G.A., and Karameris A. Elevated serum levels of the apoptosis related molecules TNF-α, Fas/Apo-1 and Bcl-2 in oral lichen planus. J Oral Pathol Med 33 (2004) 386-390
34. Sugerman P.B., Savage N.W., Walsh L.J., Zhao Z.Z., Zhou X.J., Khan A., Seymour G.J., and Bigby M. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 13 (2002) 350-365
35. Sun A., Chia J.S., Chang Y.F., and Chiang C.P. Serum interleukin-6 level is a useful marker in evaluating therapeutic effects of levamisole and Chinese medicinal herbs on patients with oral lichen planus. J Oral Pathol Med 31 (2002) 196-203
36. Tanda N., Mori S., Saito K., Ikawa K., and Sakamoto S. Expression of apoptotic signaling proteins in leukoplakia and oral lichen planus: quantitative and topographical studies. J Oral Pathol Med 29 (2000) 385-393
37. Till A., Rosenstiel P., Krippner-Heidenreich A., Mascheretti-Croucher S., Croucher P.J., Schafer H., Scheurich P., Seegert D., and Schreiber S. The Met-196 -> Arg variation of human tumor necrosis factor receptor 2 (TNFR2) affects TNF-α-induced apoptosis by impaired NF-κB signaling and target gene expression. J Biol Chem 280 (2005) 5994-6004
38. Tsuchiya N., Komata T., Matsushita M., Ohashi J., and Tokunaga K. New single nucleotide polymorphisms in the coding region of human TNFR2: association with systemic lupus erythematosus. Genes Immun 1 (2000) 501-503
39. van der Pol W., and van de Winkel J.G. IgG receptor polymorphisms: risk factors for disease. Immunogenetics 48 (1998) 222-232
40. van der Pol W.L., Jansen M.D., Sluiter W.J., van de Sluis B., Leppers-van de Straat F.G., Kobayashi T., Westendorp R.G., Huizinga T.W., and van de Winkel J.G. Evidence for non-random distribution of Fcγ receptor genotype combinations. Immunogenetics 55 (2003) 240-246
41. van de Winkel J.G., and Capel P.J. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 14 (1993) 215-221
42. Xavier G.M., de Sá A.R., Guimarães A.L., da Silva T.A., and Gomez R.S. Investigation of functional gene polymorphisms interleukin-1β, interleukin-6, interleukin-10 and tumor necrosis factor in individuals with oral lichen planus. J Oral Pathol Med 36 (2007) 476-481